Orexigen Therapeutics (OREX) Reports Q1 Loss of $4.67/Share
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q1 EPS of ($4.67), versus ($1.54) reported last year. Revenue for the quarter came in at $19.1 million versus the consensus estimate of $20 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
